Objective To observe the motion sickness among undergraduates during their first maritime practice,and to explore the relationships between gender,traditional Chinese medicine(TCM)constitution,psychological factors,susceptibility to motion sickness and nautical motion sickness.Methods A total of 120 sophomore students were selected by simple random sampling.The Constitution Classification and Determination Scale of TCM,Beck depression inventory-short form(BDI-SF),state trait anxiety inventory(STAI)and modified motion sickness susceptibility questionnaire(mMSSQ)were used for a questionnaire survey among the students.Seasickness discomfort was assessed by Graybiel scale when they first entered the rough sea.Results A total of 104 trainees completed the questionnaire.The physical constitution was mainly characterized by damp-heat,phlegm dampness,Qi deficiency,and Yang deficiency.There was no significant difference in the incidence of motion sickness among the students with different constitutions(P<0.05).Depressi on was found in 16 people(15.38%),and depression was highly correlated with the susceptibility to motion sickness and anxiety(all P<0.01).Fifty-six students(53.85%)were highly susceptible to motion sickness.All the students felt discomfort when they first entered the rough sea,and the discomfort in females was significantly stronger than that in males(P<0.01).Motion sickness occurred in 54 students,the incidence of motion sickness in females was higher than that in males(P<0.01),and the incidence of motion sickness in the students with depression was higher than that in the students without depression(P<0.01).Gender,Yang deficiency constitution,degree of depression,and susceptibility to motion sickness were significantly correlated with the motion sickness(P<0.05),and could be used as predictors of motion sickness.Conclusion There is a high incidence of motion sickness among college students during their first maritime practice.More attention should be paid to female students,and to students with Yang deficiency constitution,negative emotions(depression and anxiety)and high susceptibility to motion sickness.

Objective:To analyze the effect and safety of levonorgestrel-releasing intrauterine system(LNG-IUS) for the premenopausal patients with breast cancer who took tamoxifen as adjuvant therapy.Methods:From June 2014 to June 2016, 84 patients with breast cancer who met the inclusion criteria in the First People′s Hospital of Xiaoshan District were randomly divided into two groups according to the digital table.The treatment group (39 cases) underwent LNG-IUS insertion, while the control group (45 cases) received no LNG-IUS insertion.The general condition of patients before the use of tamoxifen and LNG-IUS was evaluated.Transvaginal ultrasound was used to measure the thickness of endometrium, hysteroscope was used for pathological examination of endometrium and the measurement of ER/PR expression, and blood lipid level was also detected.All above was done before the treatment of tamoxifen and LNG-IUS, 1 year after treatment and 2 years after treatment.Results:Before the therapy, there were no statistically significant differences between the two groups in general condition and uterine cavity condition(all P>0.05). After 1 year, the incidences of endometrial polyp, endometrial hyperplasia/secretion, benign lesion and endometrial atrophy in the treatment group were 2.6%, 5.1%, 15.4%, 76.9%, respectively, which in the control group were 6.7%, 20.0%, 17.8%, 55.6%, respectively.the differences between the two groups were statistically significant(χ 2=4.06, 4.22, all P<0.05). After 2 years, the incidences of endometrial polyp, endometrial hyperplasia/secretion, benign lesion and endometrial atrophy in the treatment group were 0.0%, 2.6%, 84.6%, respectively, which in the control group were 11.1%, 15.6%, 60.0%, respectively, the differences between the two groups were statistically significant(χ 2=4.608, 4.092, 6.203, all P<0.05). Conclusion:LNG-IUS can prevent the benign endometrial lesions of breast cancer patients caused by tamoxifen therapy after surgery, and can decrease the incidence of endometrial polyp and endometrial hyperplasia/secretion, while increase the incidence of endometrial atrophy, without increasing the recurrence risk of breast cancer.